Literature DB >> 21828136

Cell of origin strongly influences genetic selection in a mouse model of T-ALL.

Katherine E Berquam-Vrieze1, Kishore Nannapaneni, Benjamin T Brett, Linda Holmfeldt, Jing Ma, Oksana Zagorodna, Nancy A Jenkins, Neal G Copeland, David K Meyerholz, C Michael Knudson, Charles G Mullighan, Todd E Scheetz, Adam J Dupuy.   

Abstract

Identifying the normal cell from which a tumor originates is crucial to understanding the etiology of that cancer. However, retrospective identification of the cell of origin in cancer is challenging because of the accumulation of genetic and epigenetic changes in tumor cells. The biologic state of the cell of origin likely influences the genetic events that drive transformation. We directly tested this hypothesis by performing a Sleeping Beauty transposon mutagenesis screen in which common insertion sites were identified in tumors that were produced by mutagenesis of cells at varying time points throughout the T lineage. Mutation and gene expression data derived from these tumors were then compared with data obtained from a panel of 84 human T-cell acute lymphoblastic leukemia samples, including copy number alterations and gene expression profiles. This revealed that altering the cell of origin produces tumors that model distinct subtypes of human T-cell acute lymphoblastic leukemia, suggesting that even subtle changes in the cell of origin dramatically affect genetic selection in tumors. These findings have broad implications for the genetic analysis of human cancers as well as the production of mouse models of cancer.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21828136      PMCID: PMC3208280          DOI: 10.1182/blood-2011-03-343947

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  50 in total

Review 1.  Notch regulation of early thymocyte development.

Authors:  Yumi Yashiro-Ohtani; Takuya Ohtani; Warren S Pear
Journal:  Semin Immunol       Date:  2010-07-13       Impact factor: 11.130

Review 2.  Launching the T-cell-lineage developmental programme.

Authors:  Ellen V Rothenberg; Jonathan E Moore; Mary A Yui
Journal:  Nat Rev Immunol       Date:  2008-01       Impact factor: 53.106

3.  Activating Notch1 mutations are an early event in T-cell malignancy of Ikaros point mutant Plastic/+ mice.

Authors:  Simon Mantha; Maureen Ward; Jonathan McCafferty; Alan Herron; Teresa Palomero; Adolfo Ferrando; Arthur Bank; Christine Richardson
Journal:  Leuk Res       Date:  2006-07-25       Impact factor: 3.156

4.  Rapid and phosphoinositol-dependent binding of the SWI/SNF-like BAF complex to chromatin after T lymphocyte receptor signaling.

Authors:  K Zhao; W Wang; O J Rando; Y Xue; K Swiderek; A Kuo; G R Crabtree
Journal:  Cell       Date:  1998-11-25       Impact factor: 41.582

5.  Mammalian mutagenesis using a highly mobile somatic Sleeping Beauty transposon system.

Authors:  Adam J Dupuy; Keiko Akagi; David A Largaespada; Neal G Copeland; Nancy A Jenkins
Journal:  Nature       Date:  2005-07-14       Impact factor: 49.962

6.  Pathways to tumorigenesis--modeling mutation acquisition in stem cells and their progeny.

Authors:  Rina Ashkenazi; Sara N Gentry; Trachette L Jackson
Journal:  Neoplasia       Date:  2008-11       Impact factor: 5.715

7.  Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia.

Authors:  Elaine Coustan-Smith; Charles G Mullighan; Mihaela Onciu; Frederick G Behm; Susana C Raimondi; Deqing Pei; Cheng Cheng; Xiaoping Su; Jeffrey E Rubnitz; Giuseppe Basso; Andrea Biondi; Ching-Hon Pui; James R Downing; Dario Campana
Journal:  Lancet Oncol       Date:  2009-01-13       Impact factor: 41.316

8.  A histone H3 lysine 36 trimethyltransferase links Nkx2-5 to Wolf-Hirschhorn syndrome.

Authors:  Keisuke Nimura; Kiyoe Ura; Hidetaka Shiratori; Masato Ikawa; Masaru Okabe; Robert J Schwartz; Yasufumi Kaneda
Journal:  Nature       Date:  2009-05-31       Impact factor: 49.962

9.  Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia.

Authors:  Adolfo A Ferrando; Donna S Neuberg; Jane Staunton; Mignon L Loh; Christine Huard; Susana C Raimondi; Fred G Behm; Ching Hon Pui; James R Downing; D Gary Gilliland; Eric S Lander; Todd R Golub; A Thomas Look
Journal:  Cancer Cell       Date:  2002-02       Impact factor: 31.743

10.  The requirement for Notch signaling at the beta-selection checkpoint in vivo is absolute and independent of the pre-T cell receptor.

Authors:  Ivan Maillard; LiLi Tu; Arivazhagan Sambandam; Yumi Yashiro-Ohtani; John Millholland; Karen Keeshan; Olga Shestova; Lanwei Xu; Avinash Bhandoola; Warren S Pear
Journal:  J Exp Med       Date:  2006-09-11       Impact factor: 14.307

View more
  42 in total

Review 1.  In vivo functional screening for systems-level integrative cancer genomics.

Authors:  Julia Weber; Christian J Braun; Dieter Saur; Roland Rad
Journal:  Nat Rev Cancer       Date:  2020-07-07       Impact factor: 60.716

2.  Insertional mutagenesis using the Sleeping Beauty transposon system identifies drivers of erythroleukemia in mice.

Authors:  Keith R Loeb; Bridget T Hughes; Brian M Fissel; Nyka J Osteen; Sue E Knoblaugh; Jonathan E Grim; Luke J Drury; Aaron Sarver; Adam J Dupuy; Bruce E Clurman
Journal:  Sci Rep       Date:  2019-04-02       Impact factor: 4.379

3.  Human somatic cell mutagenesis creates genetically tractable sarcomas.

Authors:  Sam D Molyneux; Paul D Waterhouse; Dawne Shelton; Yang W Shao; Christopher M Watling; Qing-Lian Tang; Isaac S Harris; Brendan C Dickson; Pirashaanthy Tharmapalan; Geir K Sandve; Xiaoyang Zhang; Swneke D Bailey; Hal Berman; Jay S Wunder; Zsuzsanna Izsvák; Zsuzsanna Iszvak; Mathieu Lupien; Tak W Mak; Rama Khokha
Journal:  Nat Genet       Date:  2014-08-17       Impact factor: 38.330

4.  Diverse cells at the origin of lung adenocarcinoma.

Authors:  Samuel P Rowbotham; Carla F Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-20       Impact factor: 11.205

5.  Vav1 in hematologic neoplasms, a mini review.

Authors:  Matthew J Oberley; Deng-Shun Wang; David T Yang
Journal:  Am J Blood Res       Date:  2012-01-01

6.  Multiple cells-of-origin of mutant K-Ras-induced mouse lung adenocarcinoma.

Authors:  Kate D Sutherland; Ji-Ying Song; Min Chul Kwon; Natalie Proost; John Zevenhoven; Anton Berns
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-28       Impact factor: 11.205

7.  Dysregulated RasGRP1 responds to cytokine receptor input in T cell leukemogenesis.

Authors:  Catherine Hartzell; Olga Ksionda; Ed Lemmens; Kristen Coakley; Ming Yang; Monique Dail; Richard C Harvey; Christopher Govern; Jeroen Bakker; Tineke L Lenstra; Kristin Ammon; Anne Boeter; Stuart S Winter; Mignon Loh; Kevin Shannon; Arup K Chakraborty; Matthias Wabl; Jeroen P Roose
Journal:  Sci Signal       Date:  2013-03-26       Impact factor: 8.192

Review 8.  Mouse models of cancer: Sleeping Beauty transposons for insertional mutagenesis screens and reverse genetic studies.

Authors:  Barbara R Tschida; David A Largaespada; Vincent W Keng
Journal:  Semin Cell Dev Biol       Date:  2014-01-24       Impact factor: 7.727

Review 9.  Mouse models for lung cancer.

Authors:  Min-chul Kwon; Anton Berns
Journal:  Mol Oncol       Date:  2013-02-19       Impact factor: 6.603

10.  Adaptive immunity does not strongly suppress spontaneous tumors in a Sleeping Beauty model of cancer.

Authors:  Laura M Rogers; Alicia K Olivier; David K Meyerholz; Adam J Dupuy
Journal:  J Immunol       Date:  2013-03-08       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.